Covax: Canada defends taking vaccines from sharing scheme
https://www.bbc.com/news/world-us-canada-55932997Canada has defended its decision to draw on a supply of coronavirus vaccines from a global inoculation-sharing initiative known as Covax.
Covax pools funds from wealthier countries to help buy vaccines for themselves and low-income nations.
The scheme has announced a plan to deliver more than 330 million vaccine doses in the first half of 2021.
Canada is the only member of the G7 group of rich countries listed as a Covax beneficiary at this stage.
Other wealthier countries, including New Zealand and Singapore, have requested an early allocation as well.
Most of the first doses available, though, will be delivered to low- and middle-income countries.
Many of those countries haven't even started vaccinations. Meanwhile, Canada has vaccinated 2.29% of its population with one dose, including 48% of health workers, government data shows.
Aside from Covax, agreements for 398 million doses of vaccines have been struck by the Canadian government - more than enough to cover the country's population of 37 million.
Canada is facing temporary delays for the two vaccines currently authorised in the country. That has put Mr Trudeau under pressure to ensure a timely vaccine rollout .
Canada lacks domestic production capacity for vaccines. Moderna is only delivering about 78% of the planned number of doses this week. Pfizer vaccines have also been delayed amid efforts to scale-up European production.